149 related articles for article (PubMed ID: 9032134)
1. Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration.
Nitta A; Fukuta T; Hasegawa T; Nabeshima T
Jpn J Pharmacol; 1997 Jan; 73(1):51-7. PubMed ID: 9032134
[TBL] [Abstract][Full Text] [Related]
2. [Trial to produce animal model of Alzheimer's disease by continuous infusion of beta-amyloid protein into the rat cerebral ventricle].
Nabeshima T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Oct; 15(5):411-8. PubMed ID: 8564734
[TBL] [Abstract][Full Text] [Related]
3. Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats.
Nabeshima T; Nitta A
Tohoku J Exp Med; 1994 Nov; 174(3):241-9. PubMed ID: 7761989
[TBL] [Abstract][Full Text] [Related]
4. Improvement by nefiracetam of beta-amyloid-(1-42)-induced learning and memory impairments in rats.
Yamada K; Tanaka T; Mamiya T; Shiotani T; Kameyama T; Nabeshima T
Br J Pharmacol; 1999 Jan; 126(1):235-44. PubMed ID: 10051141
[TBL] [Abstract][Full Text] [Related]
5. beta-Amyloid protein-induced Alzheimer's disease animal model.
Nitta A; Itoh A; Hasegawa T; Nabeshima T
Neurosci Lett; 1994 Mar; 170(1):63-6. PubMed ID: 8086012
[TBL] [Abstract][Full Text] [Related]
6. Propentofylline improves learning and memory deficits in rats induced by beta-amyloid protein-(1-40).
Yamada K; Tanaka T; Senzaki K; Kameyama T; Nabeshima T
Eur J Pharmacol; 1998 May; 349(1):15-22. PubMed ID: 9669491
[TBL] [Abstract][Full Text] [Related]
7. Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide.
Nakamura S; Murayama N; Noshita T; Annoura H; Ohno T
Brain Res; 2001 Sep; 912(2):128-36. PubMed ID: 11532428
[TBL] [Abstract][Full Text] [Related]
8. NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by beta-amyloid protein in rats.
Tanaka T; Yamada K; Senzaki K; Narimatsu H; Nishimura K; Kameyama T; Nabeshima T
Eur J Pharmacol; 1998 Jul; 352(2-3):135-42. PubMed ID: 9716347
[TBL] [Abstract][Full Text] [Related]
9. Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat.
Yamaguchi Y; Kawashima S
Eur J Pharmacol; 2001 Feb; 412(3):265-72. PubMed ID: 11166290
[TBL] [Abstract][Full Text] [Related]
10. [Experimental techniques for developing new drugs acting on dementia (10)--Alzheimer's disease animal model induced by beta-amyloid protein].
Nitta A; Nabeshima T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):85-90. PubMed ID: 8905795
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo.
Yamada K; Tanaka T; Han D; Senzaki K; Kameyama T; Nabeshima T
Eur J Neurosci; 1999 Jan; 11(1):83-90. PubMed ID: 9987013
[TBL] [Abstract][Full Text] [Related]
12. Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis.
Prickaerts J; Fahrig T; Blokland A
Behav Brain Res; 1999 Jul; 102(1-2):73-88. PubMed ID: 10403017
[TBL] [Abstract][Full Text] [Related]
13. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid.
Yan JJ; Cho JY; Kim HS; Kim KL; Jung JS; Huh SO; Suh HW; Kim YH; Song DK
Br J Pharmacol; 2001 May; 133(1):89-96. PubMed ID: 11325798
[TBL] [Abstract][Full Text] [Related]
14. Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein--infused rats.
Itoh A; Nitta A; Nadai M; Nishimura K; Hirose M; Hasegawa T; Nabeshima T
J Neurochem; 1996 Mar; 66(3):1113-7. PubMed ID: 8769873
[TBL] [Abstract][Full Text] [Related]
15. A Mesenchymal Stem Cell Line Transplantation Improves Neurological Function and Angiogenesis in Intraventricular Amyloid β-Infused Rats.
Haque MA; Sheikh AM; Al Mamun A; Yano S; Hashimoto M; Shido O; Nagai A
Curr Alzheimer Res; 2018; 15(14):1331-1342. PubMed ID: 30207232
[TBL] [Abstract][Full Text] [Related]
16. Endogenous GLP-1 modulates hippocampal activity in beta-amyloid protein-treated rats.
Oka J; Suzuki E; Goto N; Kameyama T
Neuroreport; 1999 Sep; 10(14):2961-4. PubMed ID: 10549805
[TBL] [Abstract][Full Text] [Related]
17. Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of beta-amyloid (1-40).
Nag S; Yee BK; Tang F
Brain Res Bull; 1999 Nov; 50(4):251-62. PubMed ID: 10582523
[TBL] [Abstract][Full Text] [Related]
18. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat.
Wang R; Zhang HY; Tang XC
Eur J Pharmacol; 2001 Jun; 421(3):149-56. PubMed ID: 11516430
[TBL] [Abstract][Full Text] [Related]
19. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
[TBL] [Abstract][Full Text] [Related]
20. [Nerve growth factor strategy and preparation of animal model for Alzheimer-type senile dementia].
Nabeshima T
Yakugaku Zasshi; 1995 Jul; 115(7):499-512. PubMed ID: 7562397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
